Following the launch the IDF Europe survey on Access to medicines and medical devices for diabetes care in Europe, the 3 questionnaires for people with diabetes, health care professionals and institutions are now available in all language versions. Click here to access all the questionnaires!
IDF Europe is pleased to announce the launch of three questionnaires aimed at assessing access to quality medicines and medical devices in diabetes care in the European Region. In recent years, and in the context of the current financial crisis, access to diabetes care has become a key issue in countless countries around Europe.
The European Medicines Agency has published today the initial list of medicines subject to additional monitoring. This represents an important deliverable of the new European pharmacovigilance legislation. These medicines will have to display an inverted back triangle in their package leaflet and in the information for healthcare professionals called the summary of product characteristics (SmPC), together with a short sentence explaining what the triangle means.
The World Medical Association (WMA) has opened a two-month consultation on its Helsinki Declaration on medical research involving human subjects.
WMA invites all interested stakeholders to comment on the proposed changes to the text, which revised version has been posted on the WMA website. All experts and stakeholders are invited to submit their comments to the WMA secretariat no later than 15 June 2013.
EConDA, Economics of Chronic Diseases: this is the name of a European project aiming to examine the best method for assessing cost-effectiveness of interventions to prevent chronic diseases.
Submitted by sara.webber@idf.org on Mon, 04/15/2013 - 10:15
The Global Thematic Consultation on Health has confirmed that tackling diabetes and related Non-communicable Diseases (NCDs) will be central to the successor Millennium Development Goals (MDGs). The consultation, led by WHO and UNICEF from September 2012 to March 2013, united governments, UN agencies, civil society and the private sector to discuss how best to ensure the health of future generations.
Submitted by Lorenzo.Piemonte on Wed, 04/10/2013 - 12:59
In January 2013, the IDF Life for a Child Programme was contacted by Tom Etheridge, an 18 year-old with diabetes studying at Maidstone Grammar School in Kent, United Kingdom (UK). Tom is Captain of the school’s Invincible House, which comprises around 200 pupils aged 11-18. They used their house charity day to raise over £700 for Life for a Child.
A brand new Conversation MapTM dealing with aspects of diabetes management during Ramadan is set to be rolled-out across IDF's regions this year.
Following the launch the IDF Europe survey on Access to medicines and medical devices for diabetes care in Europe, the 3 questionnaires for people with diabetes, health care professionals and institutions are now available in all language versions. 
Atlanta was next-up on the tour. We did three events in total and all were amazing.
IDF Europe is pleased to announce the launch of three questionnaires aimed at assessing access to quality medicines and medical devices in diabetes care in the European Region. In recent years, and in the context of the current financial crisis, access to diabetes care has become a key issue in countless countries around Europe.
EUPATI - the European Patients' Academy on Therapeutic Innovation, has just published its 
In January 2013, the IDF Life for a Child Programme was contacted by Tom Etheridge, an 18 year-old with diabetes studying at Maidstone Grammar School in Kent, United Kingdom (UK). Tom is Captain of the school’s Invincible House, which comprises around 200 pupils aged 11-18. They used their house charity day to raise over £700 for Life for a Child.